Replies to post #200701 on Biotech Values

[DewDiligence]

GLMD 1Q16 PR/CC leave questions re liquidity/cash-burn:

http://finance.yahoo.com/news/galmed-pharmaceuticals-reports-first-quarter-120000406.html

$GLMD 1Q16 CC: Much disbelief by analysts re company's cash-burn projection.

— Roy Friedman (@DewDiligence) May 16, 2016